Incyte
INCY
#1110
Rank
S$26.08 B
Marketcap
S$132.86
Share price
2.05%
Change (1 day)
32.48%
Change (1 year)

Incyte (INCY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$2.17 Billion

According to Incyte's latest financial reports the company's total liabilities are S$2.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Incyte - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$2.71 B29.06%
2023-12-31S$2.10 B6.65%
2022-12-31S$1.97 B25.38%
2021-12-31S$1.57 B25.19%
2020-12-31S$1.25 B12.5%
2019-12-31S$1.11 B13.57%
2018-12-31S$0.98 B9.41%
2017-12-31S$0.89 B-49.06%
2016-12-31S$1.76 B49.16%
2015-12-31S$1.18 B1.95%
2014-12-31S$1.16 B11.32%
2013-12-31S$1.04 B68.65%
2012-12-31S$0.61 B-14.18%
2011-12-31S$0.72 B-3.32%
2010-12-31S$0.74 B-34.89%
2009-12-31S$1.14 B76.51%
2008-12-31S$0.64 B3.47%
2007-12-31S$0.62 B-6.86%
2006-12-31S$0.67 B2.63%
2005-12-31S$0.65 B-8.39%
2004-12-31S$0.71 B86.92%
2003-12-31S$0.38 B-11.7%
2002-12-31S$0.43 B-11.79%
2001-12-31S$0.49 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
S$104.34 B 4,695.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.68 B-68.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$118.03 B 5,324.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$149.85 B 6,786.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
S$0.41 B-81.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
S$0.43 B-80.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$81.04 B 3,624.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
S$93.8 M-95.69%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
S$0.17 B-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA